A brief review of the actions of adrenal medullary and thyroid hormones is presented and the ways in which they interact are examined. It is concluded that thyroid hormone produces the necessary intracellular environment without which the steady state and emergency actions of cathecholamines would be vitiated. In hyperthyroidism the increased concentration of thyroid hormones results in a lowering of the threshold for catecholamine action.
Introduction
The relationship between the thyroid and the adrenal glands has interested surgeons, physicians and pharmacologists for many years. The subject can be examined under two broad headings; first, the relationship between the hormones of the adrenal medulla and the thyroid, and secondly, the coincidence of separate thyroid and adrenal disease.
Adrenal medullary and thyroid relationships
Patients with phaeochromocytoma often present with symptoms which are almost identical to those of hyperthyroidism, namely weight loss, heat intolerance, sweating, palpitations, anxiety and tremor (Gifford et al., 1964) . Hyperthyroid patients, on the other hand, may sometimes show acute psychiatric features which mimic the toxic catecholamine effects of monoamine oxidase inhibiting drugs (Dewhurst, 1965) . These similarities have led to the formation of many hypotheses about the relationship between the adrenal medullary and thyroid hormones. The difficulty in reconciling and in amalgamating the different theories lies in the probable variability of this relationship in various disease states such as hypo-and hyperthyroidism.
Over the last 10 years more light has been shed on this problem and the aim of this review is to concentrate on the cellular mechanisms which seem to provide a more logical explanation for the interaction of the hormones from the two different glands (Ellis, 1956; Harrison, 1964; Waldstein, 1966; Svedmyr, 1966 (Ahlquist, 1967; Furchgott, 1967 (Furchgott, 1967) . In recent years the importance of adenosine-3',5'-phosphate (cyclic-3',5'-AMP) as an intracellular trigger mechanism activated by catecholamines has been emphasized (Sutherland & Robison, 1966) . The concentration of this potent substance depends on the activity of adenyl cyclase for its formation and of phosphodiesterase for its inactivation. Thyroid hormone increases the formation of adenyl cyclase and catecholamines have an activating effect on the enzyme so that either of them, or both, can cause an increase in the amount of cyclic-3',5'-AMP (Brodie et al., 1966) . A sudden increase in activity of adenyl cyclase triggers off a metabolic cascade (Fig. 2) which, by activating liver and muscle phosphorylase, causes the production of glucose-l-phosphate from glycogen (Bowness, 1966) and by activating adipose tissue lipase results in the breakdown of triglycerides to free fatty acid (FFA) and glycerol (Rizack, 1964; Brodie et al., 1966 It is now known that triglycerides as well as glycogen are stored in skeletal (Brodie et al., 1966) and cardiac muscle and that they are subject to the same regulatory mechanisms as in adipose tissue. It has been shown that the release of free fatty acids from myocardial triglyceride occurs quite independently of the mechanical activity of the heart (Challoner & Steinberg, 1965 (Himms-Hagen, 1967) .
Studies of the effects of adrenaline on the perfused rat heart have shown a rise in cyclic-3',5'-AMP at the start of inotropic contraction, before the concentration of phosphorylase A and of other breakdown products of glycogenolytic metabolism rises (Williamson, 1966 (Mayer, Williams & Smith, 1967) . The /3-blockers give additional evidence that the inotropic effect of catecholamines on the heart is mediated via cyclic-3',5'-AMP. Pronethalol, in a concentration which by itself produced no metabolic changes in the heart, prevented both the cyclic-3',5'-AMP rise and the inotropic response when adrenaline was added (Sutherland & Robison, 1966 (Racker, 1965) . By examining substrate and enzyme concentrations under steady conditions some idea can be gained as to the critical 'throttle steps' in cellular metabolism, and it is these points which have attracted particular attention in the search for the mode of action of thyroid hormones. The control systems are so interconnected that it is difficult to determine any primary site of action. Interest has ranged from a study of transport changes, uncoupling of oxidative phosphorylation, chelation of ions and synthesis of enzyme proteins (Tapley, 1964) . Hoch (1962 Hoch ( , 1968 (Chance & Hollunger, 1963) . The possibility that an effect on oxidative phosphorylation is important in thyrotoxicosis has been demonstrated by the finding of loose coupling in the muscle mitochondria of these patients (Hoch, 1962) . Moreover, the muscles which display the greatest degree of wasting and weakness in thyrotoxicosis are those which contain the greatest number of mitochondria (Hoch, 1962; Ramsay, 1966 (Tata, 1967) . Thus thyroid hormones seem to act in a similar fashion to growth hormone and testosterone, in that there is an increased proliferation of microsomal membranes at the same time as hormone-induced increases in cytoplasmic RNA and protein synthetic activity in vivo. A summary of the possible sites of thyroid hormone action is shown in Fig. 3 .
As has been mentioned already, it is difficult to disentangle the normal actions of the thyroid hormones from those that occur during thyrotoxicosis. In the latter situation, toxic effects may override normal control function; for example, the transport of glucose into cells is increased (Danoff & Laster, 1962) , intestinal mobility is affected (Johansson, 1966) , sodium transport is heightened (Green & Matty, 1963) (Wiswell et al., 1963; Harrison et al., 1967) .
Reflex stimuli, such as hypoglycaemia and abrupt postural changes, which normally release adrenaline and noradrenaline respectively, have not been shown to increase the output of these hormones in either hyper-or hypothyroidism (Harrison, 1961) and it has been suggested that in both situations the adrenal medulla may be under-reactive (Leak et (Maddock, Pedersen & Coller, 1937 (Svedmyr, 1966 (Bray & Goodman, 1965; Bray, 1966 (Debons & Schwartz, 1961; Felt et al., 1962) . Because thyroid hormones increase the amount of adenyl cyclase in adipose tissue (Brodie et al., 1966) , a normal quantity of circulating catecholamines is capable of enhancing the production of cyclic-3',5'-AMP. Likewise it has been shown (Hornbrook, Quinn & Siegel, 1965) that thyroid ad-ministration potentiates the catecholamines' effect on myocardial glycogenolysis, though it does not seem to produce any changes in haemodynamic responses (Aoki et al., 1965) .
A summary of possible relationships is shown in Fig. 4.   FIG. 4 . The triggering action of catecholamines on thyroxine-prepared cycles. mRNA= Messenger ribonucleic acid.
Therapeutic applications
Most of the evidence points to an enhancing effect by thyroid hormone in thyrotoxicosis on normal amounts of circulating catecholamines, Certainly many of the symptoms of the disease are explicable on this basis and this has lead to the use of adrenergic blockade in treatment. Knight (1945) Leak, 1963) and to diminish the eye signs of lid-lag and retraction (Sneddon & Turner, 1966) . One of its disadvantages is postural hypotension, which is especially liable to occur in a thyrotoxic patient with dilated peripheral blood vessels (Leak, 1963) . Reserpine has also been used (Canary et al., 1957; Wayne, 1960 (Turner, Granville-Grossman & Smart, 1965; Robillard, Klotz & Perrault, 1967) , tremor is reduced (Marsden et al., 1968) and features of anxiety and even psychosis may be eliminated (Parsons & Jewitt, 1967 The connection can probably best be explained on an autoimmune basis. It is now generally accepted that the thyroid antibodies in thyroiditis are autoantibodies (Roitt & Doniach, 1960) . Recently two groups of workers (Blizzard, Chee & Davis, 1967; Irvine, Stewart & Scarth, 1967) have demonstrated that a majority of female patients with idiopathic Addison's disease have antibodies to adrenal tissue; the association was not nearly so strong in male patients. Thyroid antibodies were also found in over half Irvine et al.'s (1967) Addisonian patients, and in a fifth of those of Blizzard et al. (1967) . Thus there is now some laboratory basis for the previously noted clinical association, but it should be noted that although serological evidence of thyroidities is common in patients with adrenalitis the converse is much rarer (Blizzard et al., 1967; Irvine et al., 1967) .
Hyperthyroidism and adrenal insufficiency Burke & Feldman (1965) reviewed twenty-six previously reported cases of hyperthyrodism associated with Addison's disease and added a further case of their own, in which they demonstrated the presence of anti-adrenal and antithyroid antibodies. Frederickson (1951) discovered that the incidence of hyperthyroidism in patients with Addison's disease was 4-4 % which is about ten times higher than would be expected in the general population.
Once again it seems likely that ultimately the connection will be found to lie in the all-embracing term of 'autoimmune disease', for it is now thought (Lancet, 1967) that long-acting thyroid stimulator, which is a e-globulin, is probably the cause of thyrotoxicosis and that it behaves as an antibody (Kabir et al., 1966) It is interesting to note in this context that two of the patients in a recent survey of thyroid and adrenal failure originally had hyperthyroidism (Carpenter et al., 1964) .
Medullary carcinoma of the thyroid and phaeochromocytoma
The association of carcinoma of the thyroid and phaeochromocytoma has recently been reviewed by Williams (1965 Williams ( , 1967 and Urbanski (1967) . Williams (1967) found that out of the thirty-five cases published, twenty-six had a carcinoma of the medullary type. This is normally a rare tumour, forming only 6.5 % of all thyroid carcinomas (Woolner et al., 1961) . Histologically it is solid, not follicular, and is characterized by islands of regular cells with an abundant granular cytoplasm and varying amounts of amyloid in the stroma (Williams, 1967) . There is a high incidence of lymph-node metastases (Williams, 1965) . Urbanski (1967) noted that of the twenty-nine cases of thyroid carcinoma and phaeochromocytoma he reviewed, the carcinoma was of the medullary type in twenty. There was a family history of thyroid carcinoma in eight and of familial phaeochromocytoma in eleven. Although only 11 % of sporadic phaeochromocytomas are bilateral (Graham, 1951) , the tumours are multiple in 46% of familial cases (Nourok, 1964) and when associated with thyroid carcinoma as many as 76% are bilateral.
The association between phaeochromocytoma and von Recklinghausen's disease is well known (Glushien, Mansuy & Litman, 1953) and Williams (1965) explains this on the basis of the neuroectodermal origins of both disorders. He thinks that there is little evidence that medullary carcinoma arises from thyroid epithelial cells and postulates that its origin, too, may be neuroectodermal. The evidence for this is strengthened by his report of two cases of multiple mucosal neuromas in association with medullary thyroid carcinoma and phaeochromocytoma (Williams & Pollock, 1966) . Urbanski (1967) noted that both thyroid medullary carcinoma and phaeochromocytoma appeared to be inherited as an autosomal dominant. Williams (1965) warned against confusing the association of thyroid medullary carcinoma and phaeochromocytoma with the better-known multiple endocrine adenoma syndrome; the two appeared to be quite distinct.
